Advances in Pathophysiology and Novel Therapeutic Strategies for Coronary No-Reflow Phenomenon

QR Code

Advances in Pathophysiology and Novel Therapeutic Strategies for Coronary No-Reflow Phenomenon

Coronary no-reflow (CNR) is the failure of blood to reperfuse ischemic myocardial tissue after restoration of the vasculature. CNR poses a significant clinical challenge in the treatment of patients with ST-segment elevation myocardial infarction (STEMI), as it increases mortality and the risk of ma...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hubert Borzuta, Wiktor Kociemba, Oliwia Bochenek, Monika Jarowicz, Agnieszka Wsół
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Biomedicines
Subjects:	coronary no-reflow myocardial infarction animal models pathophysiology ischemia/reperfusion injury microvascular obstruction
Online Access:	https://www.mdpi.com/2227-9059/13/7/1716
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of microvascular obstruction and intramyocardial hemorrhage in reperfusion injury to the heart
by: К. V. Zavadovsky, et al.
Published: (2024-04-01)

The no-reflow phenomenon: current treatment and prevention strategies
by: S. V. Dil, et al.
Published: (2025-04-01)

NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01)

PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON
by: E. V. Vyshlov, et al.
Published: (2015-02-01)

Prognostic value of no-reflow phenomenon in myocardial infarction: the role of the severity of ischemic damage
by: A. A. Frolov, et al.
Published: (2025-01-01)

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

Effectiveness of deferred coronary artery stenting in the prevention of no-reflow in patients with acute ST-segment elevation myocardial infarction
by: A. V. Azarov, et al.
Published: (2021-03-01)

Intracoronary epinephrine and verapamil in the refractory no-reflow phenomenon in patients with acute myocardial infarction
by: S. V. Dil, et al.
Published: (2022-01-01)

Phenotypes of coronary microvascular obstruction phenomenon (no-reflow) during percutaneous coronary interventions in myocardial infarction
by: A. A. Frolov, et al.
Published: (2024-01-01)

Predictors of the no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction due to stenotic coronary artery disease
by: O. O. Khaniukov, et al.
Published: (2025-04-01)

Role of biomarkers of myocardial injury and inflammation in predicting ischemia-reperfusion injury in patients with ST-segment elevation acute coronary syndrome undergoing endovascular revascularization
by: T. V. Rusak, et al.
Published: (2021-12-01)

Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
by: E. V. Konstantinova, et al.
Published: (2024-03-01)

Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
by: Mihály Medvegy, et al.
Published: (2025-07-01)

The Application of Coronary Contrast Emptying Time in Diagnosing Coronary Slow Flow Phenomenon: A Serial Case Report
by: Yudhie Tanta, et al.
Published: (2023-01-01)

Delayed endovascular surgery in patients with acute ST-segment elevation myocardial infarction due to massive culprit arterial thrombosis in the prevention of slow/no-reflow phenomenon
by: A. V. Azarov, et al.
Published: (2021-09-01)

Early Postischemic Cerebral Circulatory Disorders and Their Correction with Perftoran
by: V. V. Aleksandrin, et al.
Published: (2006-06-01)

Thrombolysis for Prevention of Cerebral No-Reflow After Cardiopulmonary Resuscitation
by: K. -A. Hossmann, et al.
Published: (2009-04-01)

Long COVID Mechanisms, Microvascular Effects, and Evaluation Based on Incidence
by: Aristotle G. Koutsiaris, et al.
Published: (2025-05-01)

Protective effect of exercise induced metabolite-3 in ischemia-reperfusion injury
by: Zijie CHENG, et al.
Published: (2025-06-01)

Cardioprotective effect of lithium ascorbate in an <i>in vivo</i> model of myocardial infarction
by: E. V. Plotnikov, et al.
Published: (2024-10-01)

Macrophage Polarization in Myocardial Ischemia&#x2012;Reperfusion Injury: Pathophysiology and Therapeutic Targets
by: Liu G, et al.
Published: (2025-07-01)

Thrombus aspiration in patients with ST-segment elevation myocardial infarction: a literature review
by: V. V. Ryabov, et al.
Published: (2023-09-01)

Mechanisms of the cardioprotective effect of lithium
by: A. V. Mukhomedzyanov, et al.
Published: (2025-04-01)

Pathogenesis and clinical significance of reperfusion arrhythmias in acute myocardial infarctio
by: V. E. Oleynikov, et al.
Published: (2024-10-01)

Novel Aspects of Cardiac Ischemia and Reperfusion Injury Mechanisms
by: T. A. Yagudin, et al.
Published: (2019-01-01)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST‐Segment–Elevation Myocardial Infarction: Influence of the Definition Used
by: José A. Barrabés, et al.
Published: (2025-06-01)

Early intravenous beta-blockers injection in patients with acute STEMI: the results of the Russian registry REGION-IM
by: T. S. Sukhinina, et al.
Published: (2024-12-01)

Research on TCM Comprehensive Treatment of DKD Based on Pathophysiological Mechanism
by: Piao L, et al.
Published: (2025-07-01)

Middle cerebral artery dissection: pathophysiology, diagnosis, and therapeutic options
by: Xiangpeng Yao, et al.
Published: (2025-08-01)

Influence of Reflow Cycles of the Pb–Free/Pb Hybrid Assembly Process on the IMCs Growth Interface of Micro-Solder Joints
by: Xinyuan He, et al.
Published: (2025-05-01)

A systematic review of silymarin and silibinin mechanisms for attenuating cerebral ischemia-reperfusion injuries
by: Hossein Mardani-Nafchi, et al.
Published: (2025-07-01)

Shifting landscapes: dynamic changes from pro- to anti-inflammatory leukocyte phenotype in myocardial ischemia/reperfusion injury
by: Pia Kröning, et al.
Published: (2025-06-01)

PATHOPHYSIOLOGICAL ASPECTS OF EXPERIMENTAL CRYO-MODELING OF PATHOLOGICAL CONDITIONS IN PANCREAS
by: A. N. Kurzanov, et al.
Published: (2016-12-01)

HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY
by: N. T. Vatutin, et al.
Published: (2014-05-01)

Pathophysiology and blood pressure measurements of hypertension in the elderly
by: Fan-Yu Chen, et al.
Published: (2025-07-01)

DIAGNOSTICS OF THE INTESTINE ISCHEMIC DAMAGES IN SOME ACUTE SURGICAL DISEASES OF ABDOMINAL CAVITY
by: Vil M. Timerbulatov, et al.
Published: (2017-09-01)

COMPARATIVE STUDY OF CARDIOPROTECTIVE EFFECT OF VARIOUS DIAMETER AND COMPOSITION LIPOSOMES DURING REPERFUSION OF THE ISOLATED RAT HEARTS AFTER NORMOTHERMIC ISCHEMIA
by: Ya. G. Toropova, et al.
Published: (2013-02-01)

Cardiac structural and functional changes in ischemia-reperfusion injury of myocardium
by: T. V. Rusak, et al.
Published: (2022-10-01)

Vasospastic angina: pathophysiology and clinical significance
by: B. I. Geltser, et al.
Published: (2020-03-01)

Pathophysiology of the Heart and Clinical Cardiac Anesthesiology
by: Yu. V. Nikiforov, et al.
Published: (2012-08-01)